In this deep-dive episode, we unpack PTSD Treatment Updates for PMHNPs: Pharmacotherapy Beyond Sertraline in 2026. PTSD pharmacotherapy has evolved well beyond first-line SSRIs. This guide covers the updated evidence for prazosin, second-generation antipsychotic augmentation, emerging MDMA-assisted therapy developments, and practical prescribing strategies for the complex, comorbid PTSD presentations PMHNPs see in clinical practice. Read the full post: https://psychnpfellowship.com/ptsd-treatment-updates-pmhnp-pharmacotherapy-beyond-sertraline-2026/